Phenylsulfamate

Phenylsulfamate

SCHEMBL4592853

N.NS(=O)(=O)Oc1ccccc1

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CA2 P00918 13/20 0.95
CA9 Q16790 13/20 0.95
CA1 P00915 12/20 0.95
STS P08842 7/20 0.62
CA12 O43570 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylsulfamate SCHEMBL605969 0.97 CA2 (1.00) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL28251303 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL4593104 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL11845500 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL3213804 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL28069795 0.95 CA2 (0.95) CA2CA9CA1STSCA12
Phenylsulfamate SCHEMBL26965424 0.85 CA2 (0.76) CA2CA9CA1STSCA12
SCHEMBL7263619 0.84 CA2 (1.00) CA2CA9CA1STSCA12
SCHEMBL9451263 0.80 CA2 (1.00) CA2CA9CA1STS
Ammonia Solution, Strong SCHEMBL6553527 0.79 CA2 (0.61) CA2CA9CA1STSCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919439-A2 PROCESS FOR BLEACHING KERATIN FIBERS The Procter and Gamble Company (US) 2008-05-14 EP claimed
EP-1919440-A2 AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER The Procter and Gamble Company (US) 2008-05-14 EP claimed
US-20070231283-A1 Process for bleaching keratin fibers PROCTER & GAMBLE COMPANY, THE 2007-10-04 US claimed
US-20070067925-A1 Agent for simultaneously lightening and coloring of fibers PROCTER & GAMBLE COMPANY, THE 2007-03-29 US claimed
WO-2007026328-A2 AGENT FOR SIMULTANEOUS LIGHTENING AND COLORING OF KERATIN FIBRES CONTAINING A SULFAMATE BLEACH BOOSTER THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
WO-2007026327-A2 PROCESS FOR BLEACHING KERATIN FIBERS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
EP-1759685-A1 Agent for simultaneous lightening and coloring of keratin fibres containing a sulfamate bleach booster Wella Aktiengesellschaft (DE) 2007-03-07 EP claimed
EP-1759684-A1 Process for bleaching keratin fibers Wella Aktiengesellschaft (DE) 2007-03-07 EP claimed
CN-108779008-B Cyanide-containing wastewater treatment agent and method for treating cyanide-containing wastewater by using same 株式会社片山化学工业研究所 2021-08-24 CN disclosed
CN-103976998-A Compounds, compositions, and methods for preventing metastasis of cancer cells AERPIO THERAPEUTICS INC 2014-08-13 CN disclosed
CN-103347565-A Compositions and methods for treating ocular edema, neovascularization, and related diseases AKEBIA THERAPEUTICS INC 2013-10-09 CN disclosed
CN-102365023-A Method of treating vascular leak syndrome AKEBIA THERAPEUTICS INC 2012-02-29 CN disclosed
CN-102365024-A Compounds, compositions and methods for preventing metastasis of cancer cells AKEBIA THERAPEUTICS INC 2012-02-29 CN disclosed
EP-1919439-A2 PROCESS FOR BLEACHING KERATIN FIBERS The Procter and Gamble Company (US) 2008-05-14 EP disclosed
WO-2007026327-A2 PROCESS FOR BLEACHING KERATIN FIBERS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO disclosed
EP-1759685-A1 Agent for simultaneous lightening and coloring of keratin fibres containing a sulfamate bleach booster Wella Aktiengesellschaft (DE) 2007-03-07 EP disclosed
EP-1759684-A1 Process for bleaching keratin fibers Wella Aktiengesellschaft (DE) 2007-03-07 EP disclosed
US-6368591-B2 COMPRISING THE BACTERIA BIFIDOBACTERIUM BIFIDUM 6-1 (CCTCC NUMBER M 98003), LACTOBACILLUS ACIDOPHILUS YIT 2004 (CCTCC NUMBER M 98004) AND STREPTOCOCCUS FAECALIS YIT 0027 (CCTCC NUMBER M 98005); TREATING ACUTE HEPATITIS, LIVER INJURIES SHANGHAI SINE PHARMACEUTICAL CORPORATION LTD. (CN) 2002-04-09 US disclosed
US-20010014322-A1 A BENEFICIAL MICROBE COMPOSITION, NEW PROTECTIVE MATERIALS FOR THE MICROBES, METHOD TO PREPARE THE SAME AND USES THEREOF SINE LABORATORY (CN) 2001-08-16 US disclosed
WO-1999059413-A1 A BENEFICIAL MICROBE COMPOSITION, NEW PROTECTIVE MATERIALS FOR THE MICROBES, THE METHOD TO PREPARE AND USES THEREOF SHANGHAI SINE PHARMACEUTICAL CORP., LTD. (CN) 1999-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070067925-A1 Agent for simultaneously lightening and coloring of fibers KIT, KRT18, H1-5 CA2 132/4885CA9 675/4885CA1 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.